Cargando…

Assessment of Early Cognitive Impairment in Patients with Clinically Isolated Syndromes and Multiple Sclerosis

Objective. The aim of our study was to investigate the frequency and pattern of cognitive impairment in patients with clinically isolated syndromes and definite diagnosis of multiple sclerosis within the last 2 years. Methods. We assessed the cognitive status of 46 patients aged 18–49 years with cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Baysal Kıraç, Leyla, Ekmekçi, Özgül, Yüceyar, Nur, Sağduyu Kocaman, Ayşe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402565/
https://www.ncbi.nlm.nih.gov/pubmed/25944978
http://dx.doi.org/10.1155/2014/637694
_version_ 1782367278263697408
author Baysal Kıraç, Leyla
Ekmekçi, Özgül
Yüceyar, Nur
Sağduyu Kocaman, Ayşe
author_facet Baysal Kıraç, Leyla
Ekmekçi, Özgül
Yüceyar, Nur
Sağduyu Kocaman, Ayşe
author_sort Baysal Kıraç, Leyla
collection PubMed
description Objective. The aim of our study was to investigate the frequency and pattern of cognitive impairment in patients with clinically isolated syndromes and definite diagnosis of multiple sclerosis within the last 2 years. Methods. We assessed the cognitive status of 46 patients aged 18–49 years with clinically isolated syndromes or definite diagnosis of multiple sclerosis who have onset of their symptoms within the last 2 years. Patients were matched with 40 healthy participants for age, sex, and educational level. Neuropsychological assessment was performed by stroop test, paced auditory serial addition test (PASAT), controlled oral word association test (COWAT), clock drawing test, trail making test (TMT), faces symbol test (FST). Hamilton Depression Scale and Modified Fatigue Impact Scale were used to quantify the severity of any depression and fatigue the subjects might suffer. Results. 19.6% of early MS/CIS group failed at 4 and more tests and had significant cognitive impairment focused on attention, executive functions, memory, and learning. No significant relationship was found between cognitive impairment and disability and fatigue scores. Discussion. Cognitive impairment can be present from the earliest stage of multiple sclerosis. It should be considered among the main manifestations of MS even in the earliest stages of the disease.
format Online
Article
Text
id pubmed-4402565
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-44025652015-05-05 Assessment of Early Cognitive Impairment in Patients with Clinically Isolated Syndromes and Multiple Sclerosis Baysal Kıraç, Leyla Ekmekçi, Özgül Yüceyar, Nur Sağduyu Kocaman, Ayşe Behav Neurol Research Article Objective. The aim of our study was to investigate the frequency and pattern of cognitive impairment in patients with clinically isolated syndromes and definite diagnosis of multiple sclerosis within the last 2 years. Methods. We assessed the cognitive status of 46 patients aged 18–49 years with clinically isolated syndromes or definite diagnosis of multiple sclerosis who have onset of their symptoms within the last 2 years. Patients were matched with 40 healthy participants for age, sex, and educational level. Neuropsychological assessment was performed by stroop test, paced auditory serial addition test (PASAT), controlled oral word association test (COWAT), clock drawing test, trail making test (TMT), faces symbol test (FST). Hamilton Depression Scale and Modified Fatigue Impact Scale were used to quantify the severity of any depression and fatigue the subjects might suffer. Results. 19.6% of early MS/CIS group failed at 4 and more tests and had significant cognitive impairment focused on attention, executive functions, memory, and learning. No significant relationship was found between cognitive impairment and disability and fatigue scores. Discussion. Cognitive impairment can be present from the earliest stage of multiple sclerosis. It should be considered among the main manifestations of MS even in the earliest stages of the disease. Hindawi Publishing Corporation 2014 2014-04-14 /pmc/articles/PMC4402565/ /pubmed/25944978 http://dx.doi.org/10.1155/2014/637694 Text en Copyright © 2014 Leyla Baysal Kıraç et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Baysal Kıraç, Leyla
Ekmekçi, Özgül
Yüceyar, Nur
Sağduyu Kocaman, Ayşe
Assessment of Early Cognitive Impairment in Patients with Clinically Isolated Syndromes and Multiple Sclerosis
title Assessment of Early Cognitive Impairment in Patients with Clinically Isolated Syndromes and Multiple Sclerosis
title_full Assessment of Early Cognitive Impairment in Patients with Clinically Isolated Syndromes and Multiple Sclerosis
title_fullStr Assessment of Early Cognitive Impairment in Patients with Clinically Isolated Syndromes and Multiple Sclerosis
title_full_unstemmed Assessment of Early Cognitive Impairment in Patients with Clinically Isolated Syndromes and Multiple Sclerosis
title_short Assessment of Early Cognitive Impairment in Patients with Clinically Isolated Syndromes and Multiple Sclerosis
title_sort assessment of early cognitive impairment in patients with clinically isolated syndromes and multiple sclerosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402565/
https://www.ncbi.nlm.nih.gov/pubmed/25944978
http://dx.doi.org/10.1155/2014/637694
work_keys_str_mv AT baysalkıracleyla assessmentofearlycognitiveimpairmentinpatientswithclinicallyisolatedsyndromesandmultiplesclerosis
AT ekmekciozgul assessmentofearlycognitiveimpairmentinpatientswithclinicallyisolatedsyndromesandmultiplesclerosis
AT yuceyarnur assessmentofearlycognitiveimpairmentinpatientswithclinicallyisolatedsyndromesandmultiplesclerosis
AT sagduyukocamanayse assessmentofearlycognitiveimpairmentinpatientswithclinicallyisolatedsyndromesandmultiplesclerosis